The global market for synthetic and natural source astaxanthin may top $1 billion by 2020.
Astaxanthin suppliers have dramatically ramped up production of the microalgae-derived ingredient in recent years, and according to two companies, the market is growing more than fast enough to support the increased supply.
Celebrated for its antioxidant benefits, astaxanthin has been a challenging ingredient to produce in the past. But a growing consumer following has driven many companies to overcome these supply challenges with expanded facilities and innovative technologies.
Today, the astaxanthin demand appears as strong as ever. According to a report from Research and Markets released in March, the global market for both synthetic and natural source astaxanthin may more than double by 2020, reaching $1.1 billion and 670 metric tons worldwide. The report also notes that a significant part of that growth is coming from the demand for natural astaxanthin on the nutraceutical and cosmetic markets.
“There is still a steady increase in the demand for natural astaxanthin,” says Janice Brown, technical support at astaxanthin supplier AstaReal (Burlington, NJ). “I believe it’s the fact that people are becoming more aware of natural astaxanthin and all the health benefits.”
AstaReal, a subsidiary of Fuji Chemical Industries Company, Ltd. (Toyama, Japan), celebrated the one-year anniversary of its astaxanthin production facility in Moses Lake, Washington on May 14. The Moses Lake factory is AstaReal’s second astaxanthin production facility, in addition to its first site in Sweden.
AstaReal reports that the Moses Lake plant “has double the production capacity of the original factory in Sweden and is currently operating at full capacity.” The second plant also makes AstaReal the only natural astaxanthin supplier with multiple manufacturing facilities, according to a press release.
Fellow astaxanthin supplier Algatechnologies (Kibbutz Ketura, Israel) has also greatly increased its supply to meet the growing demand. The recent completion of an Algatechnologies facility expansion has doubled the capacity of its AstaPure astaxanthin brand, according to Efrat Kat, director of sales and marketing. He adds that Algatechnologies is also exploring new delivery forms for its ingredients.
“One emerging category for astaxanthin is the food and beverage market, as well as all forms of liquid supplements,” says Kat. He adds that Algatechnologies has addressed these growth areas by creating “new delivery forms for the AstaPure brand in water soluble powder and emulsion.”
In a similar vein, AstaReal launched a 1.5% water-soluble, natural astaxanthin liquid last year, called AstaReal HBA. Brown says this form of astaxanthin is gaining popularity in the liquid supplement and functional beverage industries.
Nonetheless, there are still obstacles to even more growth of the astaxanthin market, including adulteration of astaxanthin products.
“The biggest obstacle that AstaReal faces is the infiltration of ‘not-up-to-par’ astaxanthin,” says Brown. “And what I mean by that is astaxanthin that is coming in off shores that are not meeting the USP [United States Pharmacopeia] monograph for astaxanthin and contain residual solvents. These sources of astaxanthin could have a negative impact on the growth of the ingredient in the market.”
A lack of consumer awareness may be another possible obstacle to further market growth, suggests Kat, who stresses the “need to invest in more education and promotional efforts.” He points to the outreach efforts of the Natural Algae Astaxanthin Association (NAXA) as one crucial aspect of the public education campaign, especially when it comes to the differences between synthetic and natural source astaxanthin.
Read more:
Are Astaxanthin Suppliers Overcoming Supply Challenges?
2015 Ingredients to Watch: Algae
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Photo © iStockphoto.com/buccaneership
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.